Current and experimental treatments of Parkinson disease: A guide for neuroscientists
出版年份 2016 全文链接
标题
Current and experimental treatments of Parkinson disease: A guide for neuroscientists
作者
关键词
-
出版物
JOURNAL OF NEUROCHEMISTRY
Volume 139, Issue -, Pages 325-337
出版商
Wiley
发表日期
2016-09-01
DOI
10.1111/jnc.13750
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Caffeine Exposure and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis of Observational Studiess
- (2017) João Costa et al. JOURNAL OF ALZHEIMERS DISEASE
- Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients
- (2016) Morten Gersel Stokholm et al. ANNALS OF NEUROLOGY
- Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation
- (2016) Cameron C. McIntyre et al. JOURNAL OF NEUROCHEMISTRY
- Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
- (2016) Dolores Vilas et al. LANCET NEUROLOGY
- Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease
- (2016) Shamik Bhattacharyya et al. MOVEMENT DISORDERS
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease
- (2015) Vincenzo Donadio et al. ANNALS OF NEUROLOGY
- Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
- (2015) Anne Stuendl et al. BRAIN
- Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease
- (2015) Karl Kieburtz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study
- (2015) Eugenia Mamikonyan et al. MOVEMENT DISORDERS
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
- (2014) Johannes Levin et al. ACTA NEUROPATHOLOGICA
- Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
- (2014) Kathrin Doppler et al. ACTA NEUROPATHOLOGICA
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Mortality in Parkinson's disease: A systematic review and meta-analysis
- (2014) Angus D. Macleod et al. MOVEMENT DISORDERS
- Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease
- (2014) B. Ritz et al. NEUROLOGY
- Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
- (2014) Ning Zhang et al. PLoS One
- PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling
- (2014) V. A. Morais et al. SCIENCE
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
- (2012) Kelvin C. Luk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway
- (2012) Li Gong et al. JOURNAL OF NEUROCHEMISTRY
- Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial
- (2012) Vincent JJ Odekerken et al. LANCET NEUROLOGY
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Activity enhances dopaminergic long-duration response in Parkinson disease
- (2012) U. Jung Kang et al. NEUROLOGY
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study
- (2012) Günther Deuschl et al. PARKINSONISM & RELATED DISORDERS
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Are synucleinopathies prion-like disorders?
- (2010) Elodie Angot et al. LANCET NEUROLOGY
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
- (2009) Damla Pinar Karpinar et al. EMBO JOURNAL
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nicotine and Parkinson's disease: Implications for therapy
- (2008) Maryka Quik et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started